Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$363,200
+$112,576 QoQ
Shares Held
1,338
+22.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#588
of 844 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $6,325,147 across 7 Diagnostics & Research names. NTRA ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,021 | $2,581,847 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,316 | $2,163,869 | |
| 3 | GH |
Guardant Health, Inc.
|
3,104 | $465,693 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,987 | $383,928 | |
| 5 | NTRA |
Natera, Inc.
This page
|
1,338 | $363,200 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,290 | $235,595 | |
| 7 | MYGN |
Myriad Genetics Inc
|
22,945 | $131,015 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,200 | 1,338 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $250,624 | 1,094 | Shares | Sole | 2026-02-13 | |
| 2024-12-31 | $285,731 | 1,805 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $536,793 | 4,957 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $370,595 | 4,052 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $223,374 | 5,048 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $1,000,137 | 18,014 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,207,711 | 30,065 | Shares | Sole | 2023-02-10 | |
| 2021-06-30 | $351,829 | 3,099 | Shares | Sole | 2021-08-10 | |
| 2020-03-31 | $245,449 | 8,220 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||